Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro

Environmental Health Perspectives

Volumn 108, Issue 2, 2000, Pages 141-145

  Paakki, Pauliina ^a   Stockmann, Helene ^b   Kantola, Marjatta ^c   Wagner, Peruka ^d   Lauper, Urs ^d   Huch, Renate ^d   Elovaara, Eivor ^b   Kirkinen, Pertti ^c   Pasanen, Markku ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e NATIONAL AGENCY FOR MEDICINES   (Finland)

Author keywords

Barbiturates; Benzodiazepines; Cocaine; Cytochrome P450; Drug metabolism; Gestation; Methadone; Opiates; Pregnancy; Smoking; Steroids

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; ALCOHOL; ANDROSTENEDIONE; AROMATASE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABIS; COCAINE; CODEINE; COTININE; CYTOCHROME P450; DIAMORPHINE; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; METHADONE; MORPHINE; OPIATE; OXYGENASE; STEROID; XENOBIOTIC AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ABUSE; ENZYME ACTIVITY; FEMALE; FINLAND; HOMEOSTASIS; HUMAN; HUMAN TISSUE; PLACENTA; PRENATAL EXPOSURE; PRIORITY JOURNAL; STEROID METABOLISM; XENOBIOTIC METABOLISM;

CANNABIS;

EID: 0034116169     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108141     Document Type: Article

References (39)

1. Gonzalez FJ. Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 13:346-352 (1992).
2. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288 (1989).
3. Thompson EAJ, Siiteri PK. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 249:5373-5378 (1974).
4. Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 24:211-229 (1994).
5. Pasanen M, Haaparanta T, Sundin M, Sivonen P, Vähäkangas K, Raunio H, Hines R, Gustafsson J-Å, Pelkonen O. Immunochemical and molecular biochemical studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 62:175-187 (1990).
6. Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, Mäenpää J, Edwards RJ, Boobis AR, Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 51:403-411 (1996).
7. Rasheed A, Hines R, McCarver-May D. Variation in induction of human placental CYP2E1: possible role is susceptibility to fetal alcohol syndrome. Toxicol Appl Pharmacol 144:396-400 (1997).
8. Traeger A, Hoffman H, Frankie H, Guntner M. Untersuchungen uber den einfluss von phenobarbital auf arzneimittelabbauende enzyme in der menschlichen plazenta, auf die feinstruktur der chorionzotten und den verlauf der serumbilirubinkonzentration neugeborener. Z Geburtshilfe Perinatol 176:397-402 (1972).
9. Pelkonen O, Jouppila P, Kärki NT. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch Int Pharmacodyn Ther 202:288-297 (1973).
10. Pienimäki P, Lampela E, Hakkola J, Arvela P, Raunio H, Vähäkangas K. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia 38:309-316 (1997).
11. Pasanen M, Raunio H, Pelkonen O. Freezing affects the activity and subcellular distribution profile of placental xenobiotic- and steroid-metabolizing enzymes. Placenta 6:527-535 (1985).
12. Honkakoski P, Lang MA. Mouse liver phenobarbital-inducible P450 system: purifiction, characterization and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Arch Biochem Biophys 273:42-57 (1989).
13. Pasanen M, Pelkonen O. Solubilization and partial purification of human placental cytochromes P-450. Biochem Biophys Res Commun 103(4):1310-1317 (1981).
14. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchronic acid. Anal Biochem 150:76-85 (1985).
15. Greenlee WF, Poland A. An improved assay of 7-ethoxy-coumarin 0-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther 205:596-605 (1978).
16. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy- and benzyl-oxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345 (1985).
17. Waxman DJ, Ko A, Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem 258:11937-11947 (1983).
18. Pasanen M. Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biol Res Pregnancy Perinatol 6 (2):94-99 (1985).
19. Elovaara E, Savolainen H, Parkki M, Aitio A, Vainio H. Neurochemical effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin in Wistar and Gunn rats. Res Commun Pathol Pharmacol 18:487-494 (1977).
20. Habig W. Pabst M, Jacoby W. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139 (1974).
21. Luukkanen L, Elovaara E, Lautala P, Taskinen J, Vainio H. Characterization of 1-hydroxypyrene as a novel marker substrate of 3-methylcholanthrene-inducible phenol UDP-glucuronosyl-transferase(s). Pharmacol Toxicol 80(3):152-158 (1997).
22. Kolonen SA, Puhakainen EV. Assessment of the automated colorimetric and the high-performance liquid chromatographic methods for nicotine intake by urine samples of smokers' smoking low- and medium-yield cigarettes. Clin Chim Acta 196:159-166 (1991).
23. Pasanen M, Pelkonen O. Xenobiotic and steroid-metabolizing monooxygenases catalyzed by cytochrome P450 and glutathione S-transferase conjugations in the human placenta and their relationships to maternal cigarette smoking. Placenta 11:75-85 (1990).
24. Wong TK, Everson RB, Hsu S-T. Potent induction of human placental monooxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet 1:721-724 (1985).
25. Hincal F. Effects of exposure to air pollution and smoking on the placental aryl hydrocarbon hydroxylase (AHH) activity. Arch Environ Health 41:377-383 (1986).
26. Obolenskaya MY, Tschaikovskaya TL, Lebedeva LM, Macewicz LL, Didenco OM, Decker K. Glutathione status of placentae from differently polluted regions of Ukraine. Eur J Obstet Gynecol Reprod Biol 71:23-30 (1997).
27. Temellini A, Giuliani L, Pacifici GM. Interindividual variability of glucuronidation and sulphation of ethinyloestradiol in human liver. Br J Clin Pharmacol 31:661-664 (1991).
28. Aitio A. UDP glucuronosyltransferase of the human placenta. Biochem Pharmacol 23:2203-2205 (1974).
29. Pasanen M, Stenbäck F, Taskinen T, Raunio H, Sivonen P, Hines R, Pelkonen O. Human placental 7-ethoxyresorufin 0-deelhylase activity: inhibition studies and immunological and molecular biological detection of P450|A|. In: Cytochrome P-450: Biochemistry and Biophysics (Schuster I, ed). London: Taylor & Francis, 1989;532-535.
30. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 290:160-166 (1991).
31. Roe D, Little B, Bawdon R, Gilstrap L. Metabolism of cocaine by human placentas: implications for fetal exposure. Am J Obstet Gynecol 163:715-718 (1990).
32. Osawa Y, Higashiyama T, Yarborough C. Diverse functions of aromatase CYT P450: catecholestrogen synthesis, cocaine N-demethylation, and other selective drug metabolism [Abstract]. In: 8th International Conference on Cytochrome P450. Lisbon:Gulbenkian Institute of Science, 1992;251.
33. Sawada M, Kitamura R, Norose T, Kitada M, Itahashi K, Kamataki T. Metabolic activation of aflatoxin B1 by human placental microsomes. J Toxicol Sci 18:129-132 (1993).
34. Toma Y, Higashiyama T, Yarborough C, Osawa Y. Diverse functions of aromatase: 0-deethylation of 7-ethoxy-coumarin. Endocrinology 137:3791-3796 (1996).
35. Sheean LA. Aromatization of androstenedione by microsomes from the human placenta after gestational alcohol consumption. Alcohol Clin Exp Res 7:93-94 (1983).
36. Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, Pasanen M. Detection of cytochrome P450 gene expression m human placenta at first trimester of pregnancy. Biochem Pharmacol 52:379-383 (1996).
37. Metzler M. Role of metabolic activation in the transplacental carcinogenicity of diethystilbestrol. Biol Res Pregnancy Perinatol 3:103-107 (1982).
38. Pasanen M, Helin-Martikainen H-L, Pelkonen O, Kirkinen P. Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro. Placenta 18:37-41 (1997).
39. Paakki P, Kirkinen P, Helin H-L, Pelkonen O, Raunio H, Pasanen M, Antepartum glucocorticoid therapy suppresses human placental steroid and xenobiotic metabolizing enzymes. Placenta (in press).